Rao Srinivas 4

4 · ATAI Life Sciences N.V. · Filed Oct 4, 2024

Form 4

Period: 2024-10-04

See Remarks

Transactions

Disposition to Issuer
Stock Option
2024-10-04−709,952→ 0 total
Exercise: $11.71Exp: 2025-08-20→ Common Shares (709,952 underlying)
Award
Stock Option
2024-10-04+1,307,408→ 1,307,408 total
Exercise: $2.44Exp: 2030-08-20→ Common Shares (1,307,408 underlying)
Award
Stock Option
2024-10-04+840,000→ 840,000 total
Exercise: $2.44Exp: 2030-08-20→ Common Shares (840,000 underlying)
Disposition to Issuer
Stock Option
2024-10-04−1,307,408→ 0 total
Exercise: $2.44Exp: 2025-08-20→ Common Shares (1,307,408 underlying)
Disposition to Issuer
Stock Option
2024-10-04−840,000→ 0 total
Exercise: $2.44Exp: 2025-08-20→ Common Shares (840,000 underlying)
Award
Stock Option
2024-10-04+709,952→ 709,952 total
Exercise: $11.71Exp: 2030-08-20→ Common Shares (709,952 underlying)

Footnotes (3)

[F1]No new stock options have been awarded. The transactions reported herein reflect the extension of the expiration date of certain pre-IPO stock options previously awarded subject to performance conditions that were not satisfied at the time of the Issuer's IPO but have subsequently been satisfied to align them with options granted under the Issuer's 2021 Incentive Award Plan, which is consistent with prevailing market practices.
[F2]The stock option is fully vested and currently exercisable.
[F3]The stock option vested as to 25% of the underlying shares on April 29, 2022, and the remaining underlying shares vest in 36 substantially equal monthly installments thereafter.

Documents

1 file